 Conference Call Scheduled for Tuesday, August 16 at 11:30 AM EDT NORTHVALE, NJ ACCESSWIRE August 15, 2022 Elite Pharmaceuticals, Inc. Elite or the CompanyOTCQB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the first quarter of fiscal year 2023 ended June 30, 2022 First Quarter. Consolidated revenues for the three-month period ended June 30, 2022, were 7.7 million, an increase of 0.62 million or 9 as compared to the comparable period of the prior fiscal year. 